FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1984173841> ?p ?o ?g. }

• W1984173841 endingPage "2444" @default.
• W1984173841 startingPage "2436" @default.
• W1984173841 abstract "We evaluated a monotherapy maintenance regimen with lopinavir/ritonavir versus continuing current combined antiretroviral treatment (cART) in HIV patients with suppressed plasma HIV-1 RNA.This was an open-label, non-inferiority, multicentre trial in 23 sites in France. Adults were randomized if they had no history of virological failure while receiving a protease inhibitor, maintained HIV-1 RNA <50 copies/mL for at least 6 months and did not change cART during the last 3 months. The primary endpoint was the proportion of patients with HIV-1 RNA <50 copies/mL at Week 48 (non-inferiority margin set at -12%) with missing data and treatment modification considered as failure. The trial has been registered in ClinicalTrials.gov under the identifier NCT00140751.At Week 48, 84% (73/87) of patients in the lopinavir/ritonavir monotherapy group met the primary endpoint compared with 88% (87/99) in the cART group [difference, -4.0%, lower limit of 90% two-sided confidence interval (CI) for difference, -12.4%]. In secondary analysis with success defined as plasma HIV-1 RNA <400 copies/mL, 87% (76/87) of patients in the lopinavir/ritonavir monotherapy group were virologically suppressed compared with 88% (87/99) in the cART group (difference, -0.5%, lower limit of 90% two-sided CI for difference, -8.5%). If antiretroviral treatment intensification was taken into account, 91% (79/87) of patients in the lopinavir/ritonavir monotherapy group met the primary endpoint compared with 88% (87/99) in the cART group (difference, +2.9%, lower limit of 90% two-sided CI for difference, -4.5%). Failures of lopinavir/ritonavir monotherapy did not show acquired resistance mutations in the protease gene.Lopinavir/ritonavir monotherapy did not achieve non-inferiority versus cART for maintaining plasma HIV-1 RNA <50 copies/mL. Nevertheless, the incidence of virological failure was low (mostly with HIV-1 RNA <400 copies/mL) and easily managed by treatment intensification." @default.
• W1984173841 created "2016-06-24" @default.
• W1984173841 creator A5008874392 @default.
• W1984173841 creator A5010797435 @default.
• W1984173841 creator A5012384299 @default.
• W1984173841 creator A5013566909 @default.
• W1984173841 creator A5054867866 @default.
• W1984173841 creator A5063547176 @default.
• W1984173841 creator A5078581047 @default.
• W1984173841 creator A5078793786 @default.
• W1984173841 creator A5080763997 @default.
• W1984173841 creator A5081460531 @default.
• W1984173841 creator A5090591213 @default.
• W1984173841 creator A5091017886 @default.
• W1984173841 date "2010-09-15" @default.
• W1984173841 modified "2023-10-18" @default.
• W1984173841 title "Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial" @default.
• W1984173841 cites W1426208733 @default.
• W1984173841 cites W1967931146 @default.
• W1984173841 cites W1979035566 @default.
• W1984173841 cites W1981443783 @default.
• W1984173841 cites W1997491132 @default.
• W1984173841 cites W2034611990 @default.
• W1984173841 cites W2042974188 @default.
• W1984173841 cites W2052991207 @default.
• W1984173841 cites W2059186442 @default.
• W1984173841 cites W2072353912 @default.
• W1984173841 cites W2079201451 @default.
• W1984173841 cites W2085243794 @default.
• W1984173841 cites W2086616853 @default.
• W1984173841 cites W2087258915 @default.
• W1984173841 cites W2088221871 @default.
• W1984173841 cites W2090596531 @default.
• W1984173841 cites W2122052356 @default.
• W1984173841 cites W2147662860 @default.
• W1984173841 cites W2155432496 @default.
• W1984173841 cites W2163110297 @default.
• W1984173841 cites W2313623892 @default.
• W1984173841 cites W2328599897 @default.
• W1984173841 cites W2337376130 @default.
• W1984173841 doi "https://doi.org/10.1093/jac/dkq327" @default.
• W1984173841 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20843990" @default.
• W1984173841 hasPublicationYear "2010" @default.
• W1984173841 type Work @default.
• W1984173841 sameAs 1984173841 @default.
• W1984173841 citedByCount "43" @default.
• W1984173841 countsByYear W19841738412012 @default.
• W1984173841 countsByYear W19841738412013 @default.
• W1984173841 countsByYear W19841738412014 @default.
• W1984173841 countsByYear W19841738412015 @default.
• W1984173841 countsByYear W19841738412016 @default.
• W1984173841 countsByYear W19841738412018 @default.
• W1984173841 countsByYear W19841738412019 @default.
• W1984173841 crossrefType "journal-article" @default.
• W1984173841 hasAuthorship W1984173841A5008874392 @default.
• W1984173841 hasAuthorship W1984173841A5010797435 @default.
• W1984173841 hasAuthorship W1984173841A5012384299 @default.
• W1984173841 hasAuthorship W1984173841A5013566909 @default.
• W1984173841 hasAuthorship W1984173841A5054867866 @default.
• W1984173841 hasAuthorship W1984173841A5063547176 @default.
• W1984173841 hasAuthorship W1984173841A5078581047 @default.
• W1984173841 hasAuthorship W1984173841A5078793786 @default.
• W1984173841 hasAuthorship W1984173841A5080763997 @default.
• W1984173841 hasAuthorship W1984173841A5081460531 @default.
• W1984173841 hasAuthorship W1984173841A5090591213 @default.
• W1984173841 hasAuthorship W1984173841A5091017886 @default.
• W1984173841 hasBestOaLocation W19841738411 @default.
• W1984173841 hasConcept C126322002 @default.
• W1984173841 hasConcept C127413603 @default.
• W1984173841 hasConcept C141071460 @default.
• W1984173841 hasConcept C142462285 @default.
• W1984173841 hasConcept C168563851 @default.
• W1984173841 hasConcept C203014093 @default.
• W1984173841 hasConcept C203092338 @default.
• W1984173841 hasConcept C2777182164 @default.
• W1984173841 hasConcept C2777275308 @default.
• W1984173841 hasConcept C2779298103 @default.
• W1984173841 hasConcept C2781392899 @default.
• W1984173841 hasConcept C2781413609 @default.
• W1984173841 hasConcept C2993143319 @default.
• W1984173841 hasConcept C3013748606 @default.
• W1984173841 hasConcept C44249647 @default.
• W1984173841 hasConcept C71924100 @default.
• W1984173841 hasConcept C78519656 @default.
• W1984173841 hasConcept C90924648 @default.
• W1984173841 hasConceptScore W1984173841C126322002 @default.
• W1984173841 hasConceptScore W1984173841C127413603 @default.
• W1984173841 hasConceptScore W1984173841C141071460 @default.
• W1984173841 hasConceptScore W1984173841C142462285 @default.
• W1984173841 hasConceptScore W1984173841C168563851 @default.
• W1984173841 hasConceptScore W1984173841C203014093 @default.
• W1984173841 hasConceptScore W1984173841C203092338 @default.
• W1984173841 hasConceptScore W1984173841C2777182164 @default.
• W1984173841 hasConceptScore W1984173841C2777275308 @default.
• W1984173841 hasConceptScore W1984173841C2779298103 @default.
• W1984173841 hasConceptScore W1984173841C2781392899 @default.
• W1984173841 hasConceptScore W1984173841C2781413609 @default.
• W1984173841 hasConceptScore W1984173841C2993143319 @default.

• next